A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 48/00 (2006.01) A61K 31/00 (2006.01) A61K 31/7088 (2006.01) A61K 31/713 (2006.01) A61K 39/395 (2006.01) A61P 37/06 (2006.01) C07K 14/71 (2006.01) C07K 16/24 (2006.01) C07K 19/00 (2006.01) C12N 15/18 (2006.01)
Patent
CA 2519835
Methods of preventing, reducing, or treating corneal transplant rejection to improve transplant survival in a subject in need thereof comprising administering an agent capable of blocking or inhibiting vascular endothelial growth factor (VEGF) are provided. The methods are useful for inhibiting or preventing corneal transplant rejection in a human subject who is the recipient of a transplanted cornea.
L'invention concerne des méthodes de prévention, de réduction ou de traitement du rejet de greffon cornéen, permettant d'améliorer la survie du greffon chez un sujet subissant une transplantation. Ces méthodes consistent à administrer un agent capable de bloquer ou d'inhiber le facteur de croissance endothéliale vasculaire (VEGF). Ces méthodes permettent d'inhiber ou de prévenir efficacement le rejet de greffon cornéen chez un sujet humain subissant une transplantation de la cornée.
Cao Jingtai
Cursiefen Claus
Wiegand Stanley
Blake Cassels & Graydon Llp
Regeneron Pharmaceuticals Inc.
The Schepens Eye Research Institute
LandOfFree
Method of treating corneal transplant rejection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating corneal transplant rejection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating corneal transplant rejection will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1748396